A neurysmAl SAH is associated with significant morbidity and mortality. Only approximately two-thirds of patients with good admission WFNS grades have a good recovery. Several events in the clinical course of patients with SAH may contribute to outcome. These may include focal and global cerebral ischemia associated with the initial hemorrhage, rebleedAcute postoperative neurological deterioration associated with surgery for ruptured intracranial aneurysm: incidence, predictors, and outcomes Object. Subarachnoid hemorrhage (SAH) results in significant morbidity and mortality, even among patients who reach medical attention in good neurological condition. Many patients have neurological decline in the perioperative period, which contributes to long-term outcomes. The focus of this study is to characterize the incidence of, characteristics predictive of, and outcomes associated with acute postoperative neurological deterioration in patients undergoing surgery for ruptured intracranial aneurysm.
ing of the aneurysm, spasm of cerebral vessels producing ischemia, hydrocephalus, and surgical and medical complications of treatment.
In spite of the increased use of endovascular coil embolization, surgical clipping during the acute phase of SAH is sometimes the preferred method to prevent rebleeding of the aneurysm, particularly in younger patients or those with certain kinds of aneurysmal anatomy. 2 For example, many neurosurgeons prefer surgical clipping for middle cerebral artery aneurysms, as evidenced by the hesitancy of clinicians to randomize patients with middle cerebral artery aneurysms to a trial of surgical clipping versus endovascular coil embolization (the ISAT). 11 Surgical clipping is often performed within a few days after the initial hemorrhage, at a time when cerebrovascular physiology is still substantially altered. 3 The combination of this underlying brain and vascular pathophysiology and the surgical intervention is known to carry a risk of acute postoperative neurological deterioration. However, the incidence of acute postoperative neurological deterioration and its relationship to long-term outcome is not well defined.
The IHAST was designed to evaluate the effectiveness of mild systemic intraoperative hypothermia (33°C) in improving neurological outcome for patients undergoing surgical treatment of acutely ruptured intracranial aneurysms. The central hypothesis was that hypothermia would decrease intraoperative injury due to ischemic phenomena associated with SAH. The study measured the neurological status of patients prior to randomization, at the start of surgery, and serially during a 3-month postoperative follow-up period. The data gathered in this study provided an opportunity to examine the incidence of acute postoperative neurological deterioration and determine whether there is an association with long-term outcomes. The specific questions posed in this analysis are: 1) What is the incidence and what are the characteristics of acute neurological deterioration seen in the postoperative period? 2) What pre-and intraoperative factors are associated with acute postoperative neurological deterioration? 3) What is the relationship between these deficits and the long-term neurological outcome?
Methods
The IHAST was an international, multicenter, randomized, and partially blinded prospective clinical trial enrolling 1001 patients. Details of trial design and primary outcomes are described elsewhere. 20 The study was approved by each participating center's local institutional review board, and informed consent was obtained from either the patients or their legal representatives. The IHAST included nonpregnant adults with a WFNS grade 4 of I, II, or III who had suffered an angiographically confirmed aneurysmal SAH no more than 14 days prior to surgery. Exclusion criteria included a body mass index greater than 35 kg/m 2 , any cold-related disorders (for example, Raynaud syndrome), and the presence of an endotracheal tube at the time of enrollment. A permuted-block randomization scheme was used, stratified by center and interval between SAH and surgery (0-7 days, 8-14 days). Two hours (or less) prior to the planned start of surgery, the patient's neurological status was reevaluated and if the WFNS grade remained I-III, the patient was enrolled via a telephone-accessed computer system. This directed the anesthesiologist to select a numbered opaque envelope containing the patient's randomized treatment assignment. The envelope was opened only after the induction of anesthesia-this constituted randomization. If, prior to induction, eligibility criteria were no longer met (for example, if the patient's neurological condition deteriorated), the envelope was not opened and the patient was not considered to have been randomized. Patients were randomized into one of 2 groups: intraoperative hypothermia (target temperature at the time of aneurysm clipping, 33°C) or normothermia (36.5°C). All study personnel, except the anesthesiologists involved in each patient's intraoperative care, were blinded to treatment assignment. All but 1 patient received nimodipine as part of their routine perioperative care.
Information regarding patients' pre-SAH health status and events occurring between the time of hospital admission and surgery was collected. Detailed events occurring intraoperatively and in the immediate perioperative period (0-2 hours postoperatively) were also recorded. Other relevant postoperative information that was collected daily included GCS scores, whether the patient was still intubated and/or was still in an intensive care unit, and the presence of DINDs. A more detailed neurological evaluation, using the NIHSS, was performed at 24 and 72 hours postoperatively and again at the time of discharge. 22 Patient discharge destination (for example, home, another acute care hospital, a rehabilitation center) was also noted.
A final follow-up examination was conducted approximately 3 months after surgery. Follow-up data were available for 1000 of 1001 randomized patients. Outcome measures included 1) the dichotomized GOS score (this was the primary outcome measure for the trial, reported as used by the TOAST [Trial of ORG 10172 in Acute Stroke Treatment] investigators 16 and based on the description in the 1981 article by Jennet et al., 6 2) the Rankin Disability Scale score, 17 3) the Barthel Activities of Daily Living Index, 10 and 4) the NIHSS score. 22 All evaluations were performed by trained examiners who were unaware of the patients' temperature group assignments, and who were certified by the University of Iowa Steering Committee.
Consistent with prior IHAST publications, acute neurological deterioration at 24 hours after surgery was defined by the presence of any one or more of the following conditions at that time: 1) a decrease of 2 or more points on the GCS as compared with the preoperative value; 2) an increase of 4 or more points on the NIHSS as compared with the preoperative value; 3) an increase of 1 or more points on the motor component of any limb on the NIHSS as compared with the preoperative value; 4) tracheal intubation; 5) death; 6) report by the anesthesiologist of a new focal neurological deficit within the first 2 hours of surgery; and 7) the diagnosis of DIND.
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Statistical Analysis
Univariate comparisons of various measures in patients with and without new acute postoperative neurological deterioration were performed using the Pearson Preoperative and intraoperative variables that differed between the neurological deterioration and no neurological deterioration groups with a univariate p value < 0.10 were evaluated using a stepwise logistic regression. Variables that remained in the final model were those associated with outcome at p < 0.05, independent of other variables. All results are 2-sided, and the univariate p values are not adjusted for multiple comparisons. Statistical analyses were performed using SAS software version 9.2.
Results
Demographic Characteristics
The 1000 patients in the trial with 3-month follow-up data averaged 52 years of age at time of enrollment; 66% were female. The preoperative neurological grade using the WFNS scale was Grade I in 66%, Grade II in 29%, and Grade III in 5%. The distribution of SAH determined by the Fisher grade showed that 34% of the cases were Grade II and 47% were Grade III, based upon the baseline CT scans. The median interval from SAH to surgery was 2 days; 90% of patients underwent surgery within the 0-to 7-day interval. Surgeons used temporary clipping in 45% of the operations.
Time Course of Neurological Injury
The timing of occurrence of neurological injury in the study is elucidated by serial NIHSS score measurements. Assessment of the NIHSS score at baseline, 24 and 72 hours postoperatively, at discharge, and 3 months postoperatively demonstrates the acute magnitude of neurological deterioration in the perioperative and immediate postoperative period, with a trend toward improving neurological status over time (Fig. 1) .
Occurrence of Postoperative Neurological Deterioration
New acute postoperative neurological deterioration at 24 hours after surgery, based on the presence of one or more criteria was observed in 426 (42.6%) of the patients. Of the 660 patients whose condition was classified at baseline as WFNS Grade I, 37.7% showed one or more signs of neurological deterioration 24 hours after surgery. In general, as the baseline NIHSS score increased, a 4-point worsening in NIHSS score 24 hours postoperatively was observed more frequently (Fig. 2) . However, even in the group of patients with baseline NIHSS score of 0 (completely normal results on neurological examination), a 4-point worsening in NIHSS at 24 hours after surgery was observed in 19% of patients (and a 2-point worsening occurred in 34% of this same patient group).
Neurological Deficit Components
Complete NIHSS scores were unavailable at 24 hours in 9.5% of patients (largely due to continued postoperative endotracheal intubation). Of the new neurological deficits, 65% were accounted for by the NIHSS motor response alone (indicating new focal motor deficit), 60% using the NIHSS total score change, and 51% by GCS score change (Fig. 3) . This indicates that the acute neurological deterioration was clinically evident from the change in motor function in the majority of cases.
Patient and Operative Factors Associated With New Postoperative Deficits
Univariate Analysis. Factors such as demographic characteristics, patient history, preoperative status, and intraoperative events and procedures were analyzed to determine which variables were associated with the occurrence of new postoperative deficits. Baseline characteristics including pre-SAH status and condition on presentation with SAH are detailed in Table 1 . A linear relationship between age and occurrence of new postoperative deficit was observed. In patients under age 50 the rate of postoperative neurological deterioration was 34%, while for those age 75 or older the rate was 63%. There did not appear to be a threshold of age associated with occurrence of a new postoperative deficit. The pre-SAH Rankin Scale score was found to be associated with occurrence of postoperative neurological deterioration: 84.5% of patients who developed postoperative neurological deterioration were asymptomatic prior to SAH, while 90.6% of patients without any postoperative neurological deterioration were asymptomatic prior to SAH (p = 0.006). Worse scores on both eye opening and verbal components of the GCS (on presentation) were associated with more frequent occurrence of postoperative neurological deterioration. Seventy-seven percent of patients without postoperative neurological deterioration demonstrated spontaneous eye opening, whereas only 69% of patients with postoperative neurological deterioration opened their eyes spontaneously (p = 0.006). Eighty-nine percent of patients without postoperative neurological deterioration were oriented on presentation, while only 74.4% of patients who showed postoperative neurological deterioration were oriented on presentation (p < 0.001). Aneurysm location was also noted to be associated with occurrence of postoperative neurological deterioration. Patients with postoperative neurological deterioration more frequently had a ruptured aneurysm of the anterior communicating artery (37.1% vs 34.1%), middle cerebral artery (21.8% vs 19.7%), or vertebrobasilar artery (7.7% vs 4.4%), whereas patients without postoperative neurological deterioration more frequently had a ruptured aneurysm of the posterior communicating artery (25.1% vs 21.8%) or other artery (16.7% vs 11.6%) (p = 0.029).
Preoperative and intraoperative events and procedures were also analyzed to assess for association with occurrence of postoperative neurological deterioration and are detailed in Tables 2-4 .
Multivariate Analysis. Those pre-and intraoperative factors that differed between the no postoperative neurological deterioration and postoperative neurological deterioration groups with a p value < 0.10 were then evaluated using a stepwise logistic regression. Variables that remained in the final model were those associated with postoperative neurological deterioration at p < 0.05, independent of other variables. These included patient age, preexisting abnormality in cardiac valve function, Fisher grade on first head CT, occurrence of any procedure before aneurysm surgery (almost exclusively the placement of ventriculostomies), systolic BP at the beginning of surgery (increased systolic BP at induction associated with increased rate of postoperative neurological decline), the use of intentional intraoperative hypotension (mean arterial pressure < 60 mm Hg for 15 consecutive minutes or more), intraoperative blood loss, duration of temporary clip application of at least 20 minutes, difficulty of aneurysm exposure, and interval (days) between SAH and surgery (Table 5) . Specifically, surgery on Day 4, 5, or 6 following SAH (Day 0 refers to the day of SAH) was associated with significantly higher rates of postoperative deficit. We also observed a variation in rates of postoperative deficits between treating medical centers (ranging from 25% to 100%).
Neurological Deterioration and Outcome
To determine whether postoperative neurological deterioration was associated with outcome, we examined the 3-month GOS scores. Among all patients who had a good outcome (3-month GOS score 1), 30.6% had neurological deterioration at 24 hours postoperatively. In contrast, 64.1% of the patients with a poor outcome (3-month GOS score 2-5) had neurological deterioration at 24 hours after surgery (p < 0.001) (Fig. 4) . Of the 426 patients with neurological deterioration at 24 hours after surgery, only 46.2% had a good outcome at 3 months, while 77.7% of those without postoperative neurological deterioration at 24 hours after surgery had a good outcome (p < 0.05) (Fig. 5) . A similar pattern was seen for all other outcome measures (Rankin Scale score, 3-month NIHSS, occurrence of DIND, and discharge home) (Fig.  5) . Vegetative survival or death occurred in 12.9% of cases in which patients exhibited postoperative neurological deterioration, compared with 1.2% in those in which they did not (p < 0.05).
Eighty-nine percent of all deaths in the study (55 of 62) occurred in patients who had postoperative neurological deterioration. Twenty-one percent of these deaths (13 of 62) occurred within 7 days of SAH, 44% (27 of 62) within 21 days, and 35% (22 of 62) after 21 days. The primary causes of death in patients with postoperative neurological deterioration were cerebral infarction or cerebral edema (69%), pneumonia or acute respiratory failure (9%), sepsis or septic shock (9%), and pulmonary embolism (7%). There was 1 death attributed primarily to SAH, 1 attributed to anoxic brain injury, 1 to brain compression (herniation), and 1 to ventricular fibrillation.
Similar patterns were observed even in patients presenting in the best clinical condition (WFNS Grade I on admission): there was a 54.6% incidence of good recovery (GOS score 1) in patients with postoperative neurological deterioration versus 82% in those without postoperative neurological deterioration in this subgroup. The vegetative survival and death rates were 9.2% and 0.5%, respectively, among patients with a baseline WFNS grade of I. Other outcome measures showed consistent results among patients with a preoperative WFNS grade of I: 3-month NIHSS scores of 8 or more were present in 14.4% of the postoperative neurological deterioration group versus 1.9% in the no neurological deterioration group (p < 0.001). Three-month Rankin Scale scores of 2 or more were observed in 45.8% of the postoperative neurological deterioration group versus 16.3% of the no neurological deterioration group (p < 0.001). DIND was observed in 28.1% of the postoperative neurological deterioration group versus 12.9% of the no neurological deterioration group (p < 0.001), and 42.2% of patients with postoperative neurological deterioration were discharged home while 82.0% of patients without postoperative neurological deterioration were discharged home (p < 0.001).
To demonstrate the magnitude of the effect of postoperative neurological deterioration on outcome, with and without the presence of DIND, a flowchart shows the influence on 3-month GOS score (Fig. 6 ). In patients with no postoperative neurological deterioration and no occurrence of DIND, poor outcomes (GOS > 1) were observed in 21%, compared with 31% among patients with DIND and no postoperative neurological deterioration, 50% among patients with postoperative neurological deterioration and no DIND, and 63% among patients with both postoperative neurological deterioration and DIND (Fig. 6 ).
Discussion
The IHAST was designed to test the effectiveness of hypothermia as a neuroprotective intervention aimed at preventing neurological deterioration in patients with SAH who presented in good clinical grade. Hypothermia proved unsuccessful in preventing long-term (3-month GOS) poor outcomes. 20 Additionally, in a subset of 441 patients who underwent temporary clipping during aneurysm surgery in IHAST, neither hypothermia nor use of supplemental neuroprotective drugs (thiopental and etomidate) was effective in preventing poor outcomes, either in the short term (24-hour neurological examination) or long term (3-month GOS).
5 Thus we sought to explore the nature of the poor neurological outcomes encountered in IHAST and better understand what factors contributed to neurological deterioration in these patients.
Principal Findings
Among SAH patients presenting for surgery in good clinical condition (WFNS Grade I-III), a substantial portion of the neurological decline contributing to 3-month neurological outcome was observed in the immediate perioperative period, within 24 hours of surgery. Fortysix percent of patients with neurological deterioration 24 hours postoperatively went on to recover from this acute perioperative neurological injury. The most common manifestations of neurological deterioration at 24 hours after surgery were development of a new motor deficit or decline in GCS or NIHSS score. New nonmotor neurological deficits and DIND composed a smaller portion of the perioperative neurological deterioration.
The occurrence of postoperative neurological deterioration was found to be associated with many pre-and intraoperative factors. Several baseline characteristics, including age, preexisting abnormality in cardiac valve function, and Fisher grade on initial head CT, were associated with postoperative neurological deterioration. Several variables that likely indicate the overall severity of the patient's condition and comorbid cardiac dysfunction were also noted to be associated with occurrence of a postoperative neurological deterioration (difficulty of aneurysm exposure, systolic BP in the operating room, and occurrence of a procedure prior to aneurysm surgery). Finally, factors reflective of surgical and anesthetic management were also noted to predict occurrence of a postoperative neurological deterioration, such as use of intentional hypotension, prolonged duration of temporary arterial occlusion, blood loss, and timing of surgery (interval between SAH and surgery). Notably, surgery on Days 4, 5, and 6 following SAH (Day 0 being the day of SAH) was associated with higher rates of neurological deterioration. While blood loss and prolonged temporary arterial occlusion may arguably be more indicative of the complexity of the aneurysm treated or of intraoperative rupture and less of surgical management or decision making, the strong association with postoperative neurological deterioration is notable.
An important and not unexpected finding of this study is the association between the occurrence of postoperative neurological deterioration and long-term outcome. Patients with postoperative neurological deterioration had much less favorable outcomes as indicated by GOS and all other outcome measures. This trend was observed even in the patients whose condition was classified as "best grade"-that is, those who presented with a WFNS grade of I. This strongly implicates the operative and perioperative period as a direct contributor to longterm neurological outcomes.
Significance of the Perioperative Period
While several studies have supported the relationship between baseline characteristics and intraoperative factors with long-term outcome, few have directed attention § Occlusive cerebrovascular disease, prior ischemic stroke, myocardial infarction, and lower extremity claudication were found more frequently in the histories of patients in the neurological deterioration than in the no neurological deterioration group (< 5%). (20) 72 (17) 184 (18) 3 77 (13) 50 (12) 127 (13) 4 47 (8) 51 (12) 98 (10) 5-6 44 (8) 51 (12) 95 (10) 10 (2) 25 (6) 35 (4) preoperative events development of significant dysrhythmia 10 (2) 18 (4) 28 (3) 0.021 patient had fever >38.5°C
20 (4) 29 (7) 49 (5) 0.018 preoperative procedures endotracheal intubation 30 (5) 39 (9) 69 (7) 0.017 any other diagnostic procedure 75 (13) 99 (23) 174 (17) <0.001 procedure associated w/ intercurrent event 37 (6) 73 (17) 110 (11) <0.001 surgical procedure since hospitalization 24 (4) 41 (10) 65 (7) 0.001 any other intercurrent event since hospitalization 17 (3) 28 (7) 45 (5) ‡ Surgeons rated the degree of brain swelling at initial dural opening on a 4-point scale: 0 = no swelling, 1 = slight swelling, no treatment needed; 2 = moderate swelling, treatment needed but no delay in surgery encountered; 3 = severe swelling requiring treatment and delaying surgery for more than 10 minutes. § Occurred intraoperatively or within 2 hours of patient's leaving operating room.
to neurological deterioration occurring in the immediate perioperative period and implications of such deterioration on outcome. In the International Cooperative Study on the Timing of Aneurysm Surgery, causes of morbidity and mortality were collected and reported. Along with initial SAH, rebleeding, and vasospasm, surgical complication was noted to be a significant cause of death and disability in patients with ruptured cerebral aneurysms, especially in patients undergoing surgery on Days 7-10 post-SAH. 7 In a 1991 study, Öhman et al. 13 reported the causes of permanent deficits in a prospective series of 265 "good-grade" (Hunt and Hess Grades I-III) aneurysmal SAH patients. Following delayed cerebral ischemia and severity of the initial hemorrhage, permanent deficits attributable to surgery were reported in 3%. Ljunggren et al. 9 also recognized surgical trauma as a major cause of poor outcome and in a series of 160 good grade aneurysmal SAH patients found that 7% had poor outcomes attributable to surgery (in addition to 11% attributable to delayed ischemic deficit and 4% attributed to severity of initial hemorrhage). Post et al. 14 reported higher rates of surgical morbidity and mortality, with moderate postoperative neurological deficit or death in 35% of 86 surgically treated aneurysmal SAH patients (30% in good grade). However, mortality comprised a large component of these poor outcomes (8% overall, 6% in good grade). We found, in a more contemporary series with lower mortality rates, a much higher rate of poor outcomes resulting from neurological deterioration in the operative/perioperative period. It is important to recognize that this higher rate of postoperative neurological deterioration is likely related to the intensive prospective manner in which the data were collected, compared with retrospective series, and may reflect more accurately the patterns of morbidity in contemporary neurosurgical care.
Other studies have directed attention to operative factors relating to poor outcomes. In a 2008 study, Chong et al. 1 focused on intraoperative and perioperative factors contributing to poor clinical outcome and development of cerebral infarction, noting duration of temporary vessel occlusion, intraoperative hypotension, and intraoperative hypoxemia to be independently associated with cerebral infarction at 6 months in a multiple logistic regression analysis. Several studies have also addressed risks associ- ated with use and prolonged duration of temporal vessel occlusion during aneurysm surgery.
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While these studies demonstrate the relationship between operative factors and outcome, they do not explore the timing of neurological decline and whether operative factors are associated with acute postoperative neurological deterioration. Very few studies have gone beyond assessment of operative factors and outcome to demonstrate a relationship between intraoperative factors and acute postoperative neurological decline. In 1995 Proust et al. 15 discussed postoperative thrombosis detected by catheter angiography as a major cause of postoperative deterioration in patients with ruptured cerebral aneurysms admitted in good clinical condition (Hunt and Hess Grades I-III). In this study, postoperative thrombosis was noted as a cause of postoperative deterioration more frequently than vasospasm or surgical trauma from prolonged retraction. Postoperative thrombosis was also reported, af- ter initial hemorrhage, as a more significant contributor to morbidity and mortality in patients with an SAH than vasospasm.
In exploring the etiology and outcome of postoperative neurological deterioration, this study demonstrates that 1) certain patients do not appear to tolerate anesthesia and surgery well (older patients and those with more significant hemorrhage or difficult aneurysm location) and 2) several operative factors may make an otherwise clinically good-grade patient more vulnerable to neurological insult at the time of surgery. Patients who tolerate surgery poorly (based on baseline characteristics) are older and have more significant initial hemorrhage (as evidenced by Fisher grade and difficulty of aneurysm exposure). These factors have been demonstrated previously to be strongly associated with outcome. 8, 18 However, this study further demonstrates that the neurological deterioration in these patients may occur in association with surgery and may not reflect initial and preoperative clinical presentation, as all patients in IHAST were in good neurological condition preoperatively. This study also demonstrates that, independent of age or severity of hemorrhage, patients may be vulnerable to neurological deterioration if they undergo surgery during an intermediate time interval (4-6 days post-SAH) or in the presence of certain comorbidities. Patients who had underlying cardiac dysfunction (either preexisting, such as abnormality in valve function or potentially related to SAH, such as ST depression occurring intraoperatively), who were noted to have increased systolic BP at induction, or who were subjected to intentional hypotension intraoperatively did not tolerate surgery well-as evidenced by higher rates of new postoperative neurological deficit. Additionally, although in general, use of temporary arterial occlusion did not predispose to postoperative neurological deterioration, those patients exposed to prolonged (> 20 minutes) temporary arterial occlusion did have a higher risk of neurological deterioration. This is also not likely related to the presence of preoperative vasospasm, as very few patients were noted to have delayed ischemic deficit preoperatively, and all patients were in good clinical condition prior to surgery. However impaired autoregulation, which is known to occur following SAH, 3, 21 may contribute to the vulnerability at surgery of those patients with an underlying cardiac dysfunction or those undergoing surgery 4-6 days post-SAH. comes in good-grade SAH patients undergoing surgery for aneurysmal SAH is neurological deterioration related to events occurring during surgery or immediately postoperatively. Avoiding surgical factors associated with occurrence of postoperative neurological deterioration and directing investigative efforts at developing improved neuroprotection for use in aneurysm surgery may significantly improve long-term neurological outcomes in SAH.
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